Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2013

01-10-2013 | Research Article

Implementation of medication reviews in community pharmacies and their effect on potentially inappropriate drug use in elderly patients

Authors: Martina Teichert, Susan Noyon Luijben, Anouk Wereldsma, Ton Schalk, Jacqueline Janssen, Michel Wensing, Peter de Smet

Published in: International Journal of Clinical Pharmacy | Issue 5/2013

Login to get access

Abstract

Background In 2008 recommendations were launched to prevent medication-related hospital admissions in the Netherlands. Elderly patients using several drugs on a chronic basis were among the target group. Pharmacy-led medication reviews (MRs) were identified as having potential for improving patient safety. Objective This observational study evaluated the implementation success rate of performing all five steps of a complete MR for patients and changes in the presence of nine issues of potentially inappropriate medication (PIM) use. This change was compared between patients with a complete MR (intervention group, IG) and a reference group (RG) who attended the same pharmacy; all patients were eligible for MR, but only selected patients formed the IG. Setting Dutch community pharmacy. Method After appropriate training, the rate of IG with complete MRs was measured by pharmacists registering the various MR steps in the MR tool. Patients were eligible for a MR if aged ≥65 years with ≥5 drugs being used chronically. Main outcome measures The success rate of implementing MRs with five steps completed; the presence of nine PIMs for both study groups. Results In pharmacies with specifically trained pharmacists, 63 % of selected patients received a complete MR. This was 12 % higher than in pharmacies without trained pharmacists. PIMs reported at study start declined in the IG and at study end had decreased by an average of 19 % (with a range between 34 and 100 % per PIM); this decrease did not significantly differ from the RG. Conclusion Additional efforts are needed to improve the implementation of pharmacist-led MRs in order to realize its full potential in general practice, and for a substantial decrease of PIMs to occur in susceptible patients. These efforts should focus on training courses and additional support using computerized systems to share information with GPs and to register MR activities, together with sufficient financial reimbursement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Leendertse A, Egberts A, Stoker L, Bemt P. Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands. Arch Intern Med. 2008;17:1890–6.CrossRef Leendertse A, Egberts A, Stoker L, Bemt P. Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands. Arch Intern Med. 2008;17:1890–6.CrossRef
2.
go back to reference van der Hooft CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BHC. Adverse drug reaction-related hospitalisations: a Nationwide Study in The Netherlands. Drug Saf. 2006;29(2):161–8.PubMedCrossRef van der Hooft CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BHC. Adverse drug reaction-related hospitalisations: a Nationwide Study in The Netherlands. Drug Saf. 2006;29(2):161–8.PubMedCrossRef
3.
go back to reference Budnitz D, Lovegrove M, Shehab N, Richards C. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2000–12.CrossRef Budnitz D, Lovegrove M, Shehab N, Richards C. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2000–12.CrossRef
4.
go back to reference Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2008;17:109–16.PubMedCrossRef Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2008;17:109–16.PubMedCrossRef
5.
go back to reference Warlé-Van Herwaarden M, Kramers C, Sturkenboom M, Van den Bemt P, De Smet P. Targeting outpatient drug safety: recommendations of the dutch HARM-wrestling task force. Drug Safety. 2012;35(3):245–59. Warlé-Van Herwaarden M, Kramers C, Sturkenboom M, Van den Bemt P, De Smet P. Targeting outpatient drug safety: recommendations of the dutch HARM-wrestling task force. Drug Safety. 2012;35(3):245–59.
6.
go back to reference Buurma H, Bouvy ML, De Smet PAGM, Floor-Schreudering A, Leufkens HGM, Egberts ACG. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.PubMedCrossRef Buurma H, Bouvy ML, De Smet PAGM, Floor-Schreudering A, Leufkens HGM, Egberts ACG. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther. 2008;33(1):17–23.PubMedCrossRef
7.
go back to reference Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PRS, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.PubMedCrossRef Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PRS, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.PubMedCrossRef
8.
go back to reference Finkers F, Maring J, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32:469–76.PubMedCrossRef Finkers F, Maring J, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32:469–76.PubMedCrossRef
9.
go back to reference Schnipper J, Kirwin J, Cotugno M, Wahlstrom S, Brown B, Tarvin E, et al. Role of pharmacists counselling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71.PubMedCrossRef Schnipper J, Kirwin J, Cotugno M, Wahlstrom S, Brown B, Tarvin E, et al. Role of pharmacists counselling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71.PubMedCrossRef
10.
go back to reference Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc. 2003;169(1):17–22. Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc. 2003;169(1):17–22.
11.
go back to reference Zermansky A, Silcock J. Is medication review by primary-care pharmacists for older people cost effective?: a narrative review of the literature, focusing on costs and benefits. Pharmacoeconomics. 2009;27(1):11–24.PubMedCrossRef Zermansky A, Silcock J. Is medication review by primary-care pharmacists for older people cost effective?: a narrative review of the literature, focusing on costs and benefits. Pharmacoeconomics. 2009;27(1):11–24.PubMedCrossRef
12.
go back to reference Sorensen L, Stokes L, Purdie D, Woodward M, Elliott R, Roberts M. Medication reviews in the community: results of a randomized, controlled effectiveness trail. British J Clin Pharmacol. 2004;58(6):648–64.CrossRef Sorensen L, Stokes L, Purdie D, Woodward M, Elliott R, Roberts M. Medication reviews in the community: results of a randomized, controlled effectiveness trail. British J Clin Pharmacol. 2004;58(6):648–64.CrossRef
13.
go back to reference Avery A, Rodgers S, Cantrill J, Armstrong S, Cresswell K, Eden M, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1310–9.PubMedCrossRef Avery A, Rodgers S, Cantrill J, Armstrong S, Cresswell K, Eden M, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1310–9.PubMedCrossRef
14.
go back to reference Stuijt C, Franssen E, Egberts A, Hudson S. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25(11):947–54.PubMedCrossRef Stuijt C, Franssen E, Egberts A, Hudson S. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25(11):947–54.PubMedCrossRef
15.
go back to reference Furniss L, Burns A, Craig S, Scobie S, Cooke J, Faragher B. Effects of a pharmacist’s medication review in nursing homes. British J Psychiatr. 2000;175:563–7.CrossRef Furniss L, Burns A, Craig S, Scobie S, Cooke J, Faragher B. Effects of a pharmacist’s medication review in nursing homes. British J Psychiatr. 2000;175:563–7.CrossRef
16.
go back to reference Leendertse A, de Koning F, Goudswaard A, Jonkhoff A, van den Bogert S, de Gier H, et al. Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study. BMC Health Serv Res. 2011;7(11):4.CrossRef Leendertse A, de Koning F, Goudswaard A, Jonkhoff A, van den Bogert S, de Gier H, et al. Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study. BMC Health Serv Res. 2011;7(11):4.CrossRef
17.
go back to reference World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo 2004. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo 2004.
18.
go back to reference Teichert M, Visser LE, Dufour M, Rodenburg E, Straus SMJM, De Smet PAGM, et al. Isotretinoin use and compliance with the Dutch pregnancy prevention programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data. Drug Saf. 2010;33(4):315–26.PubMedCrossRef Teichert M, Visser LE, Dufour M, Rodenburg E, Straus SMJM, De Smet PAGM, et al. Isotretinoin use and compliance with the Dutch pregnancy prevention programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data. Drug Saf. 2010;33(4):315–26.PubMedCrossRef
20.
go back to reference Holland R, Brooksby J, Lenaghan E, et al. Effectiveness of visits from community pharmacists for patients with heart failure. British Med J. 2007;334:1098.CrossRef Holland R, Brooksby J, Lenaghan E, et al. Effectiveness of visits from community pharmacists for patients with heart failure. British Med J. 2007;334:1098.CrossRef
21.
go back to reference Sorensen L, Stokes J, Purdie D, Woodward M, Eliott R, Roberts M. Medication reviews in the community: results of a randomized, controlled effectiveness trial. British J Clin Pharmacol. 2004;58(6):648–64.CrossRef Sorensen L, Stokes J, Purdie D, Woodward M, Eliott R, Roberts M. Medication reviews in the community: results of a randomized, controlled effectiveness trial. British J Clin Pharmacol. 2004;58(6):648–64.CrossRef
22.
go back to reference Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlun-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years and older. Arch Intern Med. 2009;169(9):894–900.PubMedCrossRef Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlun-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years and older. Arch Intern Med. 2009;169(9):894–900.PubMedCrossRef
Metadata
Title
Implementation of medication reviews in community pharmacies and their effect on potentially inappropriate drug use in elderly patients
Authors
Martina Teichert
Susan Noyon Luijben
Anouk Wereldsma
Ton Schalk
Jacqueline Janssen
Michel Wensing
Peter de Smet
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9794-8

Other articles of this Issue 5/2013

International Journal of Clinical Pharmacy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine